Delivery Method: VIA UPS and Electronic Mail Reference #: RW2001359 Product: Tobacco

Recipient: E Cigarette Empire LLC

11226 North 23rd Avenue
Suite 103
Phoenix, AZ 85029
United States

[email protected]
Issuing Office: Center for Tobacco Products

United States

Dear Jim Petty:

The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your responses, dated August 6, 2020, August 28, 2020, July 2, 2021, and July 26, 2021, in response to our Warning Letter dated July 20, 2020. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website

However, our surveillance shows you continue to offer for sale to customers in the United States other tobacco products that may be subject to market authorization requirements. FDA encourages you to discuss with your suppliers the current status of any particular tobacco product’s marketing application or any product’s marketing authorization. For additional information regarding currently marketed tobacco products that a company generally might manufacture, distribute, or sell without risking FDA enforcement, please visit our website

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.

David Rice
Branch Chief
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products

VIA Electronic Mail


Keller and Heckman LLP
Attn: Azim Chowdhury
[email protected], LLC
[email protected]

Shopify, Inc.
[email protected]